Safe Medicine Act

Safe Medicine Act

This bill addresses issues related to the manufacture of drugs, including essential medicines.

The Department of Health and Human Services, the Department of Defense, and the Department of Veterans Affairs must jointly develop and implement a strategy to increase the domestic production of essential medicines, medical countermeasures, and critical inputs.

If the Food and Drug Administration determines that a drug or active pharmaceutical ingredient is manufactured in a country that may be producing contaminated drugs or ingredients due to systemic manufacturing-related problems, the labeling for that drug or ingredient must have a boxed warning about the potential for contamination.

For government procurement purposes, the President's authority to waive certain purchasing requirements that discriminate against foreign products may not be used to waive any preferences for goods that are essential medicines, medical countermeasures, or critical inputs.

The Safe Medicine Act, also known as Bill 118 hr 5575, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to ensure the safety and effectiveness of prescription medications in the United States.

One key provision of the Safe Medicine Act is the requirement for pharmaceutical companies to conduct thorough testing and clinical trials before bringing a new drug to market. This is intended to prevent harmful or ineffective medications from being prescribed to patients.

Additionally, the bill includes measures to increase transparency in the pharmaceutical industry. This includes requiring drug manufacturers to disclose any potential conflicts of interest and financial ties to healthcare providers. The Safe Medicine Act also aims to improve the monitoring and reporting of adverse reactions to medications. This will help identify any potential safety issues with prescription drugs and allow for swift action to protect patients. Overall, the Safe Medicine Act is focused on promoting the safety and efficacy of prescription medications in the United States. By implementing stricter testing requirements, increasing transparency, and improving monitoring of adverse reactions, this bill seeks to protect the health and well-being of American consumers.